Merck & Company, Inc. P/E Ratio 2007–2025
Merck & Company, Inc. reported 14.25 of price-to-earnings ratio for fiscal 2025. That was 1.6% higher than fiscal 2024. Compared with fiscal 2020, the change was -39.6%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 14.25 | +1.6% |
| FY 2024 | 14.02 | -98.1% |
| FY 2023 | 720.01 | +4019.8% |
| FY 2022 | 17.48 | +34.5% |
| FY 2021 | 12.99 | -45.0% |
| FY 2020 | 23.61 | +21.4% |
| FY 2019 | 19.46 | -22.0% |
| FY 2018 | 24.93 | -47.5% |
| FY 2017 | 47.51 | +52.3% |
| FY 2016 | 31.19 | +27.3% |
| FY 2015 | 24.50 | +150.8% |
| FY 2014 | 9.77 | -55.7% |
| FY 2013 | 22.07 | +64.7% |
| FY 2012 | 13.41 | +14.3% |
| FY 2011 | 11.73 | -84.1% |
| FY 2010 | 73.72 | +1881.5% |
| FY 2009 | 3.72 | -14.7% |
| FY 2008 | 4.36 | -77.6% |
| FY 2007 | 19.43 | — |
Source: Merck & Company, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open MRK 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Merck & Company, Inc. reported 14.25 of price-to-earnings ratio for fiscal 2025. That was 1.6% higher than fiscal 2024. Compared with fiscal 2020, the change was -39.6%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Merck & Company, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeMerck & Company, Inc. — frequently asked questions
What is Merck & Company, Inc.'s price-to-earnings ratio?
Merck & Company, Inc. (MRK) reported price-to-earnings ratio of 14.25 for fiscal year 2025, per its SEC filings.
How has Merck & Company, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2007 and 2025, MRK's price-to-earnings ratio declined at roughly 1.7% per year (compound annual rate), from 19.43 to 14.25.
Where does this data come from?
Figures are computed from Merck & Company, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More MRK financial history
Full MRK fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →